Predictive value of serum thyroglobulin after surgery for thyroid carcinoma

Laryngoscope

Volumn 113, Issue 1, 2003, Pages 77-81

  Hall, Francis T ^a   Beasley, Nigel J ^a   Eski, Spiro J ^a   Witterick, Ian J ^a   Walfish, Paul G ^a   Freeman, Jeremy L ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Prognosis; Thyroglobulin; Thyroid neoplasms; Thyroidectomy

Indexed keywords

IODINE 131;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CLINICAL CHEMISTRY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HAZARD ASSESSMENT; HUMAN; INFORMATION PROCESSING; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROIDECTOMY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARCINOMA; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE CARE; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROBABILITY; PROGNOSIS; RADIOIMMUNOASSAY; RECURRENCE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 0037220721     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200301000-00014     Document Type: Article

References (15)

1. Van Herle AJ, Uller RP. Elevated serum thyroglobulin: A marker of metastases in differentiated thyroid carcinomas. J Clin Invest 1975;56:272-277.
2. Black EG, Cassoni A, Gimlettte TM, et al. Serum thyroglobulin in thyroid cancer. Lancet 1981;2:443-445.
3. Schlumberger M, Baudin E. Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma. Eur J Endocrinol 1998;138:249-252.
4. Blahd WH. Serum thyroglobulin in the management of thyroid cancer. J Nucl Med 1990;31:1771-1773.
5. Grunwald F, Menzel C, Fimmers R, Zamora PO, Biersack HJ. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer. J Nucl Med 1996;37:1962-1964.
6. Ronga G, Filesi M, Ventroni G, Vestri AR, Signore A. Value of the first serum thyroglobulin level after total thyroidectomy for the diagnosis of metastases from differentiated thyroid carcinoma. Eur J Nucl Med 1999;26:1448-1452.
7. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1998;104:947-953.
8. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114:1050-1058.
9. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-428.
10. Shaha AR, Shah JP, Loree TR. Risk group stratification and prognostic factors in papillary carcinoma of thyroid. Ann Surg Oncol 1996;3:534-538.
11. Girelli ME, Busnardo B, Amerio R, Casara D, Betterle C, Piccolo M. Critical evaluation of serum thyroglobulin (Tg) levels during thyroid hormone suppression therapy versus Tg levels after hormone withdrawal and total body scan: Results in 291 patients with thyroid cancer. Eur J Nucl Med 1986;11:333-335.
12. Mazzaferri EL, Kloos RT. Using recombinant human TSH in the management of well-differentiated thyroid cancer: Current strategies and future directions. Thyroid 2000;10:767-778.
13. Spencer CA, LoPresti JS, Fatemi S, Nicoloff JT. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement. Thyroid 1999;9:435-441.
14. Black EG, Sheppard MC, Hoffenberg R. Serial serum thyroglobulin measurements in the management of differentiated thyroid carcinoma. Clin Endo 1987;27:115-120.
15. Schlumberger M, Fragu P, Gardet P, Lumbroso J, Violot D, Parmentier C. A new immunoradiometric assay (IRMA) system for thyroglobulin measurement in the follow-up of thyroid cancer patients. Eur J Nucl Med 1991;18:153-157.